SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-097749
Filing Date
2024-04-16
Accepted
2024-04-16 16:11:48
Documents
22
Period of Report
2024-05-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d599560ddef14a.htm   iXBRL DEF 14A 848304
6 GRAPHIC g599560dsp155.jpg GRAPHIC 1021
7 GRAPHIC g599560dsp155a.jpg GRAPHIC 4801
8 GRAPHIC g599560dsp155b.jpg GRAPHIC 3898
9 GRAPHIC g599560dsp155c.jpg GRAPHIC 2107
10 GRAPHIC g599560g02a02.jpg GRAPHIC 22409
11 GRAPHIC g599560g27s26.jpg GRAPHIC 102952
12 GRAPHIC g599560g82i09.jpg GRAPHIC 74407
13 GRAPHIC g599560g90e67.jpg GRAPHIC 65083
  Complete submission text file 0001193125-24-097749.txt   2182936

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA spro-20231231.xsd EX-101.SCH 5513
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE spro-20231231_def.xml EX-101.DEF 5942
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20231231_lab.xml EX-101.LAB 8115
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20231231_pre.xml EX-101.PRE 5145
25 EXTRACTED XBRL INSTANCE DOCUMENT d599560ddef14a_htm.xml XML 187052
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38266 | Film No.: 24847948
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)